CAI vs OKE · rev $812.0M vs P/E 15, rev $21.67B
Caris Life Sciences, Inc. Common Stock (CAI) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
Latest reported OKE revenue for 2026-06-30 was $21.67B. Net income was $1.74B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
CAI currently screens at market cap $5.22B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the CAI and OKE stock pages for the full models.
Not investment advice.